Genetic counseling services market seen reaching $4.67 billion by 2030

The global genetic counseling services market is projected to grow from $2.91 billion in 2026 to $4.67 billion by 2030, according to The Business Research Company. The report points to personalized medicine, AI-powered genomic tools, telehealth and population screening as major growth drivers, with North America leading today and Asia-Pacific expected to grow fastest.

Why it matters: - Genetic counseling is becoming more central to how patients understand inherited disease risk, genetic test results and treatment options. - The market’s projected expansion signals broader adoption of precision medicine, preventive care and genetic screening in health systems.

What happened: - The Business Research Company forecast the genetic counseling services market will rise from $2.91 billion in 2026 to $4.67 billion by 2030. - The report puts the market on a 12.6% CAGR from 2026 through 2030. - The company also estimated the market at $2.59 billion in 2025 and $2.91 billion in 2026, implying 12.3% growth in the historic period.

The details: - Genetic counseling services help individuals and families interpret inherited-condition risks, assess disease likelihood and make decisions about family planning, prevention and treatment. - The report says rising prevalence of inherited genetic disorders, broader use of genetic testing, more hospital-based counseling, lower genome sequencing costs and stronger demand for oncology-related genetic tests supported earlier growth. - Future growth is expected to come from wider use of precision medicine, AI-powered genomic interpretation tools, telehealth in genetic counseling, preventive and predictive healthcare, and population-wide genetic screening initiatives. - Personalized medicine is a major driver because it tailors prevention, diagnosis and treatment to a person’s genetic makeup, lifestyle and environment. - In February 2024, the Personalized Medicine Coalition reported the FDA approved 16 new personalized treatments for rare diseases in 2023, up from six in 2022. - North America held the largest market share in 2025. - Asia-Pacific is expected to grow the fastest during the forecast period. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspots infographics, and updated technology and trend analysis. - A free sample of the report is available here. - The full report is available here.

Between the lines: - The forecast suggests genetic counseling is moving from a niche support service to a more routine part of genomics-driven care. - The fastest growth outlook in Asia-Pacific points to expanding demand beyond mature U.S. and European markets. - The report’s focus on AI, telehealth and screening indicates the market is being shaped as much by delivery models as by test volume.

What's next: - Health systems and providers are likely to expand counseling capacity as genetic testing becomes more common across oncology, preventive care and rare disease care. - The report expects new technology adoption and broader screening programs to keep pushing the market higher through 2030. - The Business Research Company says its Global Market Model is designed to support updated forecasting and market intelligence for the sector.

The bottom line: - Genetic counseling services are projected to see sustained double-digit growth as precision medicine, digital tools and genetic screening become more embedded in care.